Comparing Fat-Dissolving Injectable Formulations: A Buyer's Guide

Clinics building out an injection-lipolysis menu are not choosing between one product and "none" — they are choosing between several distinct formulation families, each with a different active ingredient, tolerability profile, and manufacturing origin. Understanding those differences supports better purchasing decisions and a more informed conversation with patients about what to expect. For an overview of how injection lipolysis works and how it is delivered, see Fat-Dissolving Injections: Mechanism, Candidacy and Treatment Course. This overview is educational and is not an injection protocol.

Deoxycholic-Acid-Based Formulations

Aqualyx and standalone deoxycholic acid solutions remain the most established formulation family in this category, built around the same bile-salt mechanism the body uses naturally to break down fat. Clinics and patients commonly report a more noticeable burning or stinging sensation during and immediately after treatment with deoxycholic-acid-based products compared with some newer formulations — a point worth discussing at consultation so patients know what to expect, even though it is generally transient.

Phosphatidylcholine-Based Formulations

Dermaheal LL takes a related but distinct approach, combining phosphatidylcholine — a fat emulsifier derived from soy lecithin — with carnitine, an amino acid derivative associated with supporting lipid metabolism. Formulations in this family are generally reported as more comfortable during treatment than deoxycholic-acid-based options, which is a relevant differentiator when tolerability is a deciding factor for a particular patient.

Peptide-Complex Formulations

A newer generation of products takes a different approach again, using targeted peptide complexes rather than a bile salt or emulsifier. Prostrolane Inner-B is a well-known example, developed specifically for localised fat reduction in areas such as the abdomen, buttocks, thighs, and submental region, and — like the phosphatidylcholine-based options — is generally reported as more comfortable during treatment than deoxycholic-acid formulations.

Sourcing and Origin Considerations

These formulation families also differ in manufacturing origin, which is relevant to clinics managing supply chains and regulatory documentation: deoxycholic-acid products are commonly sourced from Italian and Spanish manufacturers, while several well-known phosphatidylcholine and peptide-complex formulations are manufactured in South Korea. Working with a supplier that can provide clear batch and regulatory documentation matters regardless of which formulation family a clinic chooses to stock.

Choosing Between Formulations

There is no single "best" option across the board; the right formulation for a given patient depends on the treatment area, the patient's tolerance for procedural discomfort, and the clinic's own experience with a given product line. Many clinics stock more than one formulation family precisely so they can match the product to the patient rather than offering a single default. Complementary aftercare products, such as Aqualyx body lotion, are also worth having available to support the treated area between sessions, alongside general guidance on the lifestyle factors that support the clearance of dissolved fat.

The Takeaway

Injection lipolysis is not a single product category but a small family of distinct formulations — deoxycholic-acid, phosphatidylcholine, and peptide-complex based — each with different tolerability characteristics and manufacturing origins. Stocking more than one gives a clinic the flexibility to match the formulation to the patient rather than the other way around.

Compare deoxycholic-acid, phosphatidylcholine, and peptide-complex formulations on the body contouring range.